Literature DB >> 23464730

The role of phosphorus in the pathophysiology of chronic kidney disease.

Rebecca F Geddes1, Natalie C Finch, Harriet M Syme, Jonathan Elliott.   

Abstract

OBJECTIVE: To review the human and veterinary literature on the role of phosphorus in the pathophysiology of chronic kidney disease (CKD) and to explore why control of plasma phosphorus concentration is an important goal in the management of patients with this disease. DATA SOURCES: Human and veterinary studies, reviews, clinical reports, textbooks, and recent research findings focused on phosphate homeostasis and CKD patient management. HUMAN DATA SYNTHESIS: Recent studies using rodent models and human patients with CKD have focused on trying to elucidate the role of the phosphatonins, predominantly fibroblast growth factor-23, in phosphate homeostasis and the pathophysiology of secondary renal hyperparathyroidism (SRHP). Fibroblast growth factor-23 is now considered to be a key regulator of plasma phosphorus concentration in people but has only recently been investigated in companion animal species. VETERINARY DATA SYNTHESIS: Cross-sectional studies of naturally occurring CKD in dogs and cats have shown hyperphosphatemia and SRHP to be highly prevalent and associated with increased morbidity and mortality in these patients. Experimental studies of surgically induced renal impairment in the dog and cat, and cases of naturally occurring CKD have emphasized the ability of renal care diets to modify plasma phosphorus and parathyroid hormone concentrations. Evidence from these studies indicates that maintaining plasma phosphorus concentrations to within the International Renal Interest Society targets for CKD patients improves survival time and reduces clinical manifestations of hyperphosphatemia and SRHP.
CONCLUSIONS: The maintenance of plasma phosphorus concentrations in to within the International Renal Interest Society targets is recommended in management of CKD patients. The discovery of the phosphatonins has improved understanding of the mechanisms involved in phosphorus homeostasis and SRHP and may lead to improved ability to monitor and manage these patients. © Veterinary Emergency and Critical Care Society 2013.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23464730     DOI: 10.1111/vec.12032

Source DB:  PubMed          Journal:  J Vet Emerg Crit Care (San Antonio)        ISSN: 1476-4431


  10 in total

1.  A plasma calcium-phosphorus product can be used to predict the lifespan of dogs with chronic kidney disease.

Authors:  Matías C Lucero; Francisco J Duque; María Gil; Patricia Ruiz; Beatriz Macías-García; José Igancio Cristóbal; Concepción Zaragoza; Rafael Barrera
Journal:  Can Vet J       Date:  2019-12       Impact factor: 1.008

2.  Efficacy, acceptability and tolerability of the new oral phosphate binder Lenziaren® in healthy cats fed a standard diet.

Authors:  Jonathan N King; Heidi L Erasmus; Peet C Delport; Ina Cj Bester; Wolfgang Seewald
Journal:  BMC Vet Res       Date:  2014-10-28       Impact factor: 2.741

3.  Impact of Increasing Dietary Calcium Levels on Calcium Excretion and Vitamin D Metabolites in the Blood of Healthy Adult Cats.

Authors:  Nadine Paßlack; Bettina Schmiedchen; Jens Raila; Florian J Schweigert; Friederike Stumpff; Barbara Kohn; Konrad Neumann; Jürgen Zentek
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

4.  Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease.

Authors:  D Hendrik N van den Broek; Yu-Mei Chang; Jonathan Elliott; Rosanne E Jepson
Journal:  J Vet Intern Med       Date:  2018-04-27       Impact factor: 3.333

5.  Laparoscopic resection of bilateral perinephric pseudocyst in a pediatric feline patient.

Authors:  Margaret Amparo Placer; Cindy McManis
Journal:  JFMS Open Rep       Date:  2019-05-29

6.  Effects of dietary phosphates from organic and inorganic sources on parameters of phosphorus homeostasis in healthy adult dogs.

Authors:  Britta Dobenecker; Sven Reese; Sarah Herbst
Journal:  PLoS One       Date:  2021-02-19       Impact factor: 3.240

Review 7.  Vitamin D Metabolism and Its Role in Mineral and Bone Disorders in Chronic Kidney Disease in Humans, Dogs and Cats.

Authors:  Fernanda C Chacar; Márcia M Kogika; Rafael V A Zafalon; Marcio A Brunetto
Journal:  Metabolites       Date:  2020-12-04

8.  Urinary Fractional Excretion of Phosphorus in Dogs with Spontaneous Chronic Kidney Disease.

Authors:  Cínthia Ribas Martorelli; Márcia Mery Kogika; Fernanda Chicharo Chacar; Douglas Segalla Caragelasco; Ana Carolina Brandão de Campos Fonseca Pinto; Carla Aparecida Batista Lorigados; Lúcia Conceição Andrade
Journal:  Vet Sci       Date:  2017-12-14

9.  The Source Matters-Effects of High Phosphate Intake from Eight Different Sources in Dogs.

Authors:  Britta Dobenecker; Ellen Kienzle; Stephanie Siedler
Journal:  Animals (Basel)       Date:  2021-12-04       Impact factor: 2.752

10.  Risk factors and implications associated with renal mineralization in chronic kidney disease in cats.

Authors:  Pak-Kan Tang; Rosanne E Jepson; Yu-Mei Chang; Rebecca F Geddes; Mark Hopkinson; Jonathan Elliott
Journal:  J Vet Intern Med       Date:  2022-01-19       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.